Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 10 studies | 27% ± 11% | |
cardiac muscle cell | 5 studies | 32% ± 11% | |
Mueller cell | 5 studies | 33% ± 9% | |
fibroblast | 3 studies | 31% ± 7% | |
epithelial cell | 3 studies | 21% ± 3% |
Insufficient scRNA-seq data for expression of PPP1R3C at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 97% | 9622.99 | 220 / 226 | 87% | 39.62 | 355 / 406 |
brain | 71% | 2448.98 | 1886 / 2642 | 99% | 39.23 | 698 / 705 |
bladder | 86% | 2148.95 | 18 / 21 | 51% | 25.56 | 255 / 504 |
esophagus | 95% | 6750.41 | 1368 / 1445 | 32% | 12.75 | 59 / 183 |
kidney | 33% | 663.24 | 29 / 89 | 90% | 66.42 | 815 / 901 |
adrenal gland | 53% | 985.73 | 138 / 258 | 62% | 17.53 | 143 / 230 |
prostate | 46% | 1101.44 | 113 / 245 | 68% | 12.60 | 343 / 502 |
pancreas | 39% | 784.62 | 129 / 328 | 73% | 15.70 | 130 / 178 |
breast | 35% | 899.23 | 161 / 459 | 73% | 36.75 | 818 / 1118 |
skin | 63% | 1619.12 | 1135 / 1809 | 42% | 21.59 | 198 / 472 |
blood vessel | 99% | 15286.67 | 1321 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 56.44 | 77 / 80 |
muscle | 96% | 14656.31 | 768 / 803 | 0% | 0 | 0 / 0 |
heart | 95% | 9541.53 | 817 / 861 | 0% | 0 | 0 / 0 |
uterus | 51% | 1327.21 | 87 / 170 | 41% | 23.15 | 186 / 459 |
lung | 39% | 932.45 | 223 / 578 | 48% | 8.93 | 550 / 1155 |
stomach | 49% | 1428.38 | 176 / 359 | 20% | 4.25 | 58 / 286 |
intestine | 50% | 1092.24 | 487 / 966 | 14% | 3.03 | 76 / 527 |
adipose | 35% | 1018.22 | 416 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 33% | 6.87 | 15 / 45 |
ovary | 12% | 297.07 | 21 / 180 | 12% | 2.20 | 50 / 430 |
thymus | 3% | 60.58 | 18 / 653 | 9% | 1.36 | 56 / 605 |
spleen | 2% | 29.12 | 4 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0005979 | Biological process | regulation of glycogen biosynthetic process |
GO_0005978 | Biological process | glycogen biosynthetic process |
GO_0005977 | Biological process | glycogen metabolic process |
GO_0000164 | Cellular component | protein phosphatase type 1 complex |
GO_0005829 | Cellular component | cytosol |
GO_2001069 | Molecular function | glycogen binding |
GO_0060090 | Molecular function | molecular adaptor activity |
GO_0008157 | Molecular function | protein phosphatase 1 binding |
GO_0005515 | Molecular function | protein binding |
GO_0019903 | Molecular function | protein phosphatase binding |
GO_0004722 | Molecular function | protein serine/threonine phosphatase activity |
Gene name | PPP1R3C |
Protein name | Protein phosphatase 1 regulatory subunit 3C (Protein phosphatase 1 regulatory subunit 5) (PP1 subunit R5) (Protein targeting to glycogen) (PTG) |
Synonyms | PPP1R5 |
Description | FUNCTION: Acts as a glycogen-targeting subunit for PP1 and regulates its activity. Activates glycogen synthase, reduces glycogen phosphorylase activity and limits glycogen breakdown. Dramatically increases basal and insulin-stimulated glycogen synthesis upon overexpression in a variety of cell types. . |
Accessions | Q9UQK1 ENST00000238994.6 |